- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 487/04 - Ortho-condensed systems
Patent holdings for IPC class C07D 487/04
Total number of patents in this class: 22730
10-year publication summary
|
1243
|
1284
|
1391
|
1419
|
1492
|
1392
|
1488
|
1694
|
1618
|
1383
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4820 |
497 |
| F. Hoffmann-La Roche AG | 7933 |
366 |
| Novartis AG | 10623 |
318 |
| Janssen Pharmaceutica N.V. | 3351 |
318 |
| Hoffmann-La Roche Inc. | 3533 |
299 |
| Gilead Sciences, Inc. | 2094 |
288 |
| Merck Sharp & Dohme LLC | 3737 |
288 |
| Merck Patent GmbH | 5759 |
280 |
| Incyte Corporation | 1037 |
274 |
| Boehringer Ingelheim International GmbH | 4635 |
238 |
| Genentech, Inc. | 4015 |
210 |
| Dana-Farber Cancer Institute, Inc. | 2623 |
198 |
| Pfizer Inc. | 3401 |
190 |
| Takeda Pharmaceutical Company Limited | 2717 |
185 |
| AstraZeneca AB | 2858 |
164 |
| Incyte Holdings Corporation | 663 |
157 |
| Abbvie Inc. | 1815 |
130 |
| The Regents of the University of California | 20289 |
121 |
| LG Chem, Ltd. | 17679 |
115 |
| Amgen Inc. | 4258 |
115 |
| Other owners | 17979 |